Cargando…

Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16

Objectives: To analyze the significance of the number of positive lymph nodes in oral squamous cell carcinoma (SCC) stratified by p16. Methods: A total of 674 patients were retrospectively enrolled and divided into 4 groups based on their number of positive lymph nodes (0 vs. 1–2 vs. 3–4 vs. ≥5). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peng, Fang, Qigen, Yang, Yanjie, Chen, Defeng, Du, Wei, Liu, Fei, Luo, Ruihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969991/
https://www.ncbi.nlm.nih.gov/pubmed/33747901
http://dx.doi.org/10.3389/fonc.2021.545433
_version_ 1783666345352626176
author Li, Peng
Fang, Qigen
Yang, Yanjie
Chen, Defeng
Du, Wei
Liu, Fei
Luo, Ruihua
author_facet Li, Peng
Fang, Qigen
Yang, Yanjie
Chen, Defeng
Du, Wei
Liu, Fei
Luo, Ruihua
author_sort Li, Peng
collection PubMed
description Objectives: To analyze the significance of the number of positive lymph nodes in oral squamous cell carcinoma (SCC) stratified by p16. Methods: A total of 674 patients were retrospectively enrolled and divided into 4 groups based on their number of positive lymph nodes (0 vs. 1–2 vs. 3–4 vs. ≥5). The Kaplan-Meier method was used to calculate the disease-free survival (DFS) and disease-specific survival (DSS) rates. Cox model was used to evaluate the independent risk factor. Results: p16 showed positivity in 85 patients with a rate of 12.6%. In patients with p16 negativity, the 5-year DFS rates were 52%, 39%, and 21% in patients with 0, 1–2, and 3–4 positive lymph nodes, respectively, in patients with ≥5 positive lymph nodes, all patients developed recurrence within 2 years after operation, the difference was significant; the 5-year DSS rates were 60, 38, and 18% in patients with 0, 1–2, and 3–4 positive lymph nodes, respectively, in patients with ≥5 positive lymph nodes, all patients died within 4-years after operation. The difference was significant. In p16 positivity patients, the 3-year DFS rates were 41% and 17% in patients with 0–2 and ≥3 positive lymph nodes, respectively, the difference was significant; the 3-year DSS rates were 84 and 46% in patients with 0–2 and ≥3 positive lymph nodes, the difference was significant. Conclusions: The number of positive lymph nodes is significantly associated with the survival in oral SCC, its survival effect is not affected by p16 status.
format Online
Article
Text
id pubmed-7969991
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79699912021-03-19 Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16 Li, Peng Fang, Qigen Yang, Yanjie Chen, Defeng Du, Wei Liu, Fei Luo, Ruihua Front Oncol Oncology Objectives: To analyze the significance of the number of positive lymph nodes in oral squamous cell carcinoma (SCC) stratified by p16. Methods: A total of 674 patients were retrospectively enrolled and divided into 4 groups based on their number of positive lymph nodes (0 vs. 1–2 vs. 3–4 vs. ≥5). The Kaplan-Meier method was used to calculate the disease-free survival (DFS) and disease-specific survival (DSS) rates. Cox model was used to evaluate the independent risk factor. Results: p16 showed positivity in 85 patients with a rate of 12.6%. In patients with p16 negativity, the 5-year DFS rates were 52%, 39%, and 21% in patients with 0, 1–2, and 3–4 positive lymph nodes, respectively, in patients with ≥5 positive lymph nodes, all patients developed recurrence within 2 years after operation, the difference was significant; the 5-year DSS rates were 60, 38, and 18% in patients with 0, 1–2, and 3–4 positive lymph nodes, respectively, in patients with ≥5 positive lymph nodes, all patients died within 4-years after operation. The difference was significant. In p16 positivity patients, the 3-year DFS rates were 41% and 17% in patients with 0–2 and ≥3 positive lymph nodes, respectively, the difference was significant; the 3-year DSS rates were 84 and 46% in patients with 0–2 and ≥3 positive lymph nodes, the difference was significant. Conclusions: The number of positive lymph nodes is significantly associated with the survival in oral SCC, its survival effect is not affected by p16 status. Frontiers Media S.A. 2021-03-04 /pmc/articles/PMC7969991/ /pubmed/33747901 http://dx.doi.org/10.3389/fonc.2021.545433 Text en Copyright © 2021 Li, Fang, Yang, Chen, Du, Liu and Luo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Peng
Fang, Qigen
Yang, Yanjie
Chen, Defeng
Du, Wei
Liu, Fei
Luo, Ruihua
Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16
title Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16
title_full Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16
title_fullStr Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16
title_full_unstemmed Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16
title_short Survival Significance of Number of Positive Lymph Nodes in Oral Squamous Cell Carcinoma Stratified by p16
title_sort survival significance of number of positive lymph nodes in oral squamous cell carcinoma stratified by p16
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969991/
https://www.ncbi.nlm.nih.gov/pubmed/33747901
http://dx.doi.org/10.3389/fonc.2021.545433
work_keys_str_mv AT lipeng survivalsignificanceofnumberofpositivelymphnodesinoralsquamouscellcarcinomastratifiedbyp16
AT fangqigen survivalsignificanceofnumberofpositivelymphnodesinoralsquamouscellcarcinomastratifiedbyp16
AT yangyanjie survivalsignificanceofnumberofpositivelymphnodesinoralsquamouscellcarcinomastratifiedbyp16
AT chendefeng survivalsignificanceofnumberofpositivelymphnodesinoralsquamouscellcarcinomastratifiedbyp16
AT duwei survivalsignificanceofnumberofpositivelymphnodesinoralsquamouscellcarcinomastratifiedbyp16
AT liufei survivalsignificanceofnumberofpositivelymphnodesinoralsquamouscellcarcinomastratifiedbyp16
AT luoruihua survivalsignificanceofnumberofpositivelymphnodesinoralsquamouscellcarcinomastratifiedbyp16